Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites
- PMID: 2029807
- DOI: 10.2165/00003088-199120020-00007
Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites
Abstract
The effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) 500 mg and its metabolites were studied in 8 healthy men. The mean residence times for paracetamol or its metabolites were significantly altered by change in posture or by sleep, whereas other pharmacokinetic parameters were unchanged. The change in mean residence time is consistent with a faster absorption of paracetamol during ambulation. The present data suggest that the proposed posture-related changes in volume of distribution do not exist, and that there is no pharmacokinetic basis for a headache being relieved by taking paracetamol and lying down.
Similar articles
-
The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations.J Pharm Pharmacol. 2003 Oct;55(10):1345-50. doi: 10.1211/0022357021846. J Pharm Pharmacol. 2003. PMID: 14607015 Clinical Trial.
-
The influence of posture on the pharmacokinetics of orally administered nifedipine.Br J Clin Pharmacol. 1992 Oct;34(4):332-6. doi: 10.1111/j.1365-2125.1992.tb05639.x. Br J Clin Pharmacol. 1992. PMID: 1457267 Free PMC article. Clinical Trial.
-
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002. Clin Ther. 2009. PMID: 19302912 Clinical Trial.
-
Pharmacokinetics of paracetamol in patients with stomach cancer.Pol J Pharmacol Pharm. 1988 Jan-Feb;40(1):41-5. Pol J Pharmacol Pharm. 1988. PMID: 3237557
-
[Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues].Drugs. 2003;63 Spec No 2:5-13. Drugs. 2003. PMID: 14758786 Review. French.
Cited by
-
Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.Clin Pharmacokinet. 1992 Oct;23(4):292-310. doi: 10.2165/00003088-199223040-00005. Clin Pharmacokinet. 1992. PMID: 1395362 Review.
-
Chronotherapy for Hypertension.Curr Hypertens Rep. 2018 Sep 28;20(11):97. doi: 10.1007/s11906-018-0897-4. Curr Hypertens Rep. 2018. PMID: 30267334 Free PMC article. Review.
-
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature.Br J Pharmacol. 2022 Jun;179(11):2538-2557. doi: 10.1111/bph.15822. Epub 2022 Mar 15. Br J Pharmacol. 2022. PMID: 35170019 Free PMC article. Review.
-
Drug structure-transport relationships.J Pharmacokinet Pharmacodyn. 2010 Dec;37(6):541-73. doi: 10.1007/s10928-010-9174-0. Epub 2010 Nov 24. J Pharmacokinet Pharmacodyn. 2010. PMID: 21107662 Free PMC article. Review.
-
Influence of posture on pharmacokinetics.Eur J Clin Pharmacol. 2009 Feb;65(2):109-19. doi: 10.1007/s00228-008-0579-2. Epub 2008 Oct 21. Eur J Clin Pharmacol. 2009. PMID: 18936930 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical